(in-person) courses and conferences effective July 1, 2021 and available COVID-19 online education and resources.
Mayo Clinic Workshop in Plasma Cell Disorders: Robert Kyle Symposium 2021 - LIVESTREAM
Course Directors: Shaji Kumar, M.D., Prashant Kapoor, M.D. and Wilson Gonsalves, M.D.
May 22, 2021 (LIVESTREAM - CT) will provide education to Medical Professionals for CME Credit.
May 23, 2021 (LIVESTREAM - CT) will provide education to patients, families and caregivers in the areas of Multiple Myeloma, Al Amyloidosis, and Waldenstrom Macroglobulinemia.
There are numerous new and established drug therapies and protocols for plasma cell disorders, including AL amyloidosis, Waldenstrom’s macroglobulinemia and multiple myeloma. This CME course introduces health care professionals at all levels to the latest practices in the treatment of plasma cell disorders. The conference provides “bench-to-bedside” overview of novel drug therapies for the general oncologist, resident, fellow, or advanced practice provider who is unfamiliar with current clinical trials and treatments.
- Panel discussions with top researchers and clinicians who are leading clinical trials that will benefit patients seen by attendees
- Content directly focused on the types of clinical cases general hematologists/oncologists are seeing in their clinics and hospitals
- Q&A with faculty about real clinical scenarios
- Special recognition of Dr. Robert Kyle, Mayo Clinic emeritus, who will be present and speak at the event
Concurrent with the scientific program for physicians and healthcare professionals, there will be a separate patient-oriented symposium. Registration for the patient symposium is free for patients and their family members. Go to the Patient Symposiums register
|Allied Health, Nurse Practitioners, Physician Assistant, Retirees||$60|
|Patient Symposiums||No Fee|
This course is designed for Physicians, Physician Assistants, Nurse Practitioners and Nurses.
Upon conclusion of this program, participants should be able to:
- Interpret new, practice-relevant data in diagnosing and risk stratifying monoclonal plasma cell disorders.
- Integrate evidence-based treatment strategies into clinical practice for Monoclonal gammopathies.
- Integrate supportive care approaches into treatment of plasma cell disorders .
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
- 6.25 AMA PRA Category 1 Credit™
- 6.25 Attendance
VIRTUAL EXHIBIT HALL
Welcome to the Virtual Exhibit Hall. Analogous to booths at scientific conferences, this is a space where companies share information about their products and services, showcase their latest innovations, and connect with attendees, faculty and course directors. Check out the "booths" below to learn about each exhibitor and get connected!
If you are interested in exhibit space, please contact Corinne Irish
Click on Exhibitor Logo to Access the Virtual Booth
Virtual Exhibit Hall is paid advertising. The use of the Site and the Content, including Third Party Content, is at your own risk.